基金funded by Major New Medication Development Program(2012ZX09303005-002)the National Key Clinical Disciplines at Shanghai Mental Health Center(Office of Medical Affairs,Ministry of Health,2011-873+2 种基金OMA-MH,2011-873)provided by the Hefei Zhongkeda Biological and Technology Companyapproved by the Chinese Food and Drug Administration(2005l02694)
